GEODE CAPITAL MANAGEMENT, LLC - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 53 filers reported holding AQUESTIVE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 1.8%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$698,731
+3.0%
456,565
+11.1%
0.00%
Q2 2023$678,112
+53.5%
410,977
+6.0%
0.00%
Q1 2023$441,835
+126500.3%
387,5750.0%0.00%
Q4 2022$349
-99.9%
387,575
+5.9%
0.00%
Q3 2022$428,000
+174.4%
365,899
+49.7%
0.00%
Q2 2022$156,000
-76.5%
244,362
-4.0%
0.00%
Q1 2022$664,000
-32.9%
254,497
+0.1%
0.00%
Q4 2021$989,000
+3.3%
254,296
+15.8%
0.00%
Q3 2021$957,000
+9.9%
219,640
-0.0%
0.00%
Q2 2021$871,000
-52.8%
219,642
-38.1%
0.00%
Q1 2021$1,845,000
+10.1%
354,856
+13.3%
0.00%
Q4 2020$1,676,000
+25.4%
313,324
+13.8%
0.00%
Q3 2020$1,337,000
+1.8%
275,418
+1.8%
0.00%
Q2 2020$1,314,000
+303.1%
270,446
+81.4%
0.00%
Q1 2020$326,000
-68.2%
149,089
-15.4%
0.00%
Q4 2019$1,024,000
+913.9%
176,136
+453.2%
0.00%
Q3 2019$101,000
-27.3%
31,842
-4.1%
0.00%
Q2 2019$139,000
-73.3%
33,201
-55.9%
0.00%
Q1 2019$520,000
-6.5%
75,333
-14.8%
0.00%
Q4 2018$556,000
+27.8%
88,416
+255.1%
0.00%
Q3 2018$435,00024,8980.00%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 9,810,958$16,188,081100.00%
Vahanian & Associates Financial Planning Inc. 725,208$1,196,5933.78%
Bracebridge Capital, LLC 428,571$707,1420.39%
Latash Investments, LLC 243,134$401,1710.32%
XTX Topco Ltd 138,145$227,9390.04%
ARMISTICE CAPITAL, LLC 1,158,000$1,910,7000.03%
OCCUDO QUANTITATIVE STRATEGIES LP 84,355$139,1860.01%
Hillsdale Investment Management Inc. 66,600$109,8900.01%
D.B. Root & Company, LLC 12,950$21,3680.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 147,856$243,9620.01%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders